University of California San Francisco
Give to UCSF
Displaying 841 - 870 of 1111
-
-
Archive: Melanoma Treatment Shows Promise at UCSF
-
Archive: Deadly Liver Cancer May Be Triggered by Cells Changing Identity, UCSF Study Shows
UCSF researchers triggered cellular transformation — and caused tumors to form in mice — by activating just two genes, a discovery that suggests drugs that are able to target those genes may provide a way to treat the deadly cancer, known as cholangiocarcinoma.
-
Archive: The Great Cancer Cell Mix Up
-
Archive: A Protein Weakens Cancer Drug
-
Archive: Support for Cancer Patients Is Just Phone Call Away
Cancer patients across the country have a new way to navigate through difficult treatment decisions and communicate better with their doctors. “Open to Options,’’ which recently launched nationally, was developed in conjunction with UCSF to guide patients in making critical health decisions.
-
Archive: Secrets of Lung Cancer Drug Resistance Revealed at UCSF
People with lung cancer who are treated with the drug Tarceva face a daunting uncertainty: although their tumors may initially shrink, it's not a question of whether their cancer will return—it's a question of when. And for far too many, it happens far too soon.
-
Archive: Low-Dose Vitamin D May Not Prevent Fractures in Women - What about High Doses?
<p>Vitamin D and calcium to prevent bone fractures in healthy, postmenopausal women does not work, at least at low supplemental doses, according to the United States Preventive Services Task Force.</p>
-
Archive: Cancer's Next Magic Bullet May Be Magic Shotgun
A new approach to drug design, pioneered by a group of researchers at UCSF and Mt. Sinai, New York, promises to help identify future drugs to fight cancer and other diseases that will be more effective and have fewer side effects.
-
Archive: Breast Cancer Risk Can Be Lowered By Avoiding Unnecessary Medical Imaging
The single thing that a woman can do to lower her risk of breast cancer is to avoid unnecessary medical imaging, says Rebecca Smith-Bindman, MD, a professor of radiology and biomedical imaging, epidemiology and biostatistics at UCSF, who contributed to a new Institute of Medicine report.
-
Archive: Drug Slows Advanced Prostate Cancer
-
Archive: New Cancer Data Shine Spotlight On The Secret Committees That Make Medicine's Toughest Decisions
-
Archive: A Drug for Advanced Melanoma Is Found to Prolong Patients' Lives
-
Archive: Hormone-blocking Pill Zytiga Slows Prostate Cancer Growth
-
Archive: FDA to Let Women Try New Breast Drugs Earlier
-
Archive: Interrupting Prostate Cancer Treatment Could Shorten Life, Study Finds
-
Archive: Johnson & Johnson Prostate Cancer Drug Impresses
-
Archive: Zytiga: Hormone-Blocking Pill Slows Prostate Cancer Growth, Study Finds
-
Archive: Study: Hormone Pill Slows Prostate Cancer's Growth
-
Archive: J&J's Zytiga Slows Prostate Cancer While Easing Pain In Study
-
Archive: A Glimpse Inside Construction of UCSF Medical Center at Mission Bay
<p>Construction of UCSF Medical Center at Mission Bay is well underway, with the building’s exterior panels, glass, and interior studs being installed.</p>
-
Archive: Media Advisory: UCSF Hosts Bone Marrow Transplant Reunion
To celebrate nearly a quarter-century of advances in hematology and transplantation, UCSF is holding a reunion of patients from the UCSF Medical Center who have undergone bone marrow transplants.
-
Archive: Cancer and Infertility: Dodging the 'Double Blow'
-
Archive: Compassionate Use Gives Lifeline to Needy Patients
-
Archive: 'Thin Red Line' Around Breast Cancer
A pioneering approach to imaging breast cancer in mice has revealed new clues about why the human immune system often fails to attack tumors and keep cancer in check. This observation, by scientists at the University of California, San Francisco (UCSF), may help to reveal new approaches to cancer immunotherapy.
-
Archive: UCSF Team Reports on microRNA Knockout Mouse Resource
-
Archive: When to Get a Mammogram
-
Archive: Health, Prognosis Not Taken Into Account When Treating Older Lung Cancer Patients, Study Finds
In a study of patients 65 and older with non-small-cell lung cancer (NSCLC), younger patients were more likely to receive treatment than older patients, regardless of overall health and prognosis.
-
Archive: NCI Grant to Aid Oral Cancer Genomic Marker Research
-
Archive: Brain Surgery for Epilepsy Underutilized
Ten years ago, a landmark clinical trial in Canada demonstrated the unequivocal effectiveness of brain surgeries for treating uncontrolled epilepsy, but since then the procedure has not been widely adopted — in fact, it is dramatically underutilized according to a new UCSF study.